PASADENA, CA, USA I April 26, 2025 I GenVivo, Inc., a clinical-stage biopharmaceutical company pioneering a patented, off-the-shelf vector platform that ...

Data demonstrate potential superiority of antibody-based T cell engager CDR404 over TCR-based approaches, consistent with emerging Phase 1 trial signals of ...

Alexandre Mugwaneza, 69, visited his wife’s paternal cousin, who was battling prostate cancer. The image of a once-active man now frail and bedridden stayed with him. Though Mugwaneza felt fine, that ...